Cardiovascular risk profiles in a lupus cohort

What do different calculators tell us?

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

Background Cardiovascular disease (CVD) is the leading cause of death worldwide and this risk is increased in patients with SLE who may not conform to traditional cardiovascular risk profiles. Aims To determine the prevalence of high CVD risk among patients with SLE calculated using different risk calculators, and to characterise those identified as high risk. Methods A cross-sectional analysis to estimate CVD risk using the Framingham Risk Equation (Framingham score) and an SLE-specific CVD risk equation (SLE score) was undertaken using data from a single centre cohort. The characteristics of patients identified as â high risk' by the SLE score only (the â missed group') were compared with those identified by the Framingham score (the â conventional group'). Results 146 patients were included; 22 (15%) and 44 (30%) were determined to be at â high risk' based on the Framingham and SLE scores, respectively. Patients in the â missed group' were less likely to have traditional risk factors and were more likely to be female (81% vs 50%; p=0.03), younger (mean age 54 vs 69 years p<0.01) and have lower systolic blood pressure (132 vs 143 mm Hg; p=0.05). Of those deemed high risk, only a minority were treated to target blood pressure and lipid levels. Conclusions A large proportion of patients with SLE could be re-classified as high risk using a formula that incorporates SLE disease-related parameters. These patients have different profiles to those identified using a conventional risk model. Optimal CVD risk assessment and management warrants further attention in SLE.

Original languageEnglish
Article number000212
Number of pages5
JournalLupus Science and Medicine
Volume4
Issue number1
DOIs
Publication statusPublished - 1 Jul 2017

Keywords

  • cardiovascular risk
  • risk assessment
  • Systemic lupus erythematosus

Cite this

@article{28fe1310386b4bb1a2a1f1c2364a3de1,
title = "Cardiovascular risk profiles in a lupus cohort: What do different calculators tell us?",
abstract = "Background Cardiovascular disease (CVD) is the leading cause of death worldwide and this risk is increased in patients with SLE who may not conform to traditional cardiovascular risk profiles. Aims To determine the prevalence of high CVD risk among patients with SLE calculated using different risk calculators, and to characterise those identified as high risk. Methods A cross-sectional analysis to estimate CVD risk using the Framingham Risk Equation (Framingham score) and an SLE-specific CVD risk equation (SLE score) was undertaken using data from a single centre cohort. The characteristics of patients identified as {\^a} high risk' by the SLE score only (the {\^a} missed group') were compared with those identified by the Framingham score (the {\^a} conventional group'). Results 146 patients were included; 22 (15{\%}) and 44 (30{\%}) were determined to be at {\^a} high risk' based on the Framingham and SLE scores, respectively. Patients in the {\^a} missed group' were less likely to have traditional risk factors and were more likely to be female (81{\%} vs 50{\%}; p=0.03), younger (mean age 54 vs 69 years p<0.01) and have lower systolic blood pressure (132 vs 143 mm Hg; p=0.05). Of those deemed high risk, only a minority were treated to target blood pressure and lipid levels. Conclusions A large proportion of patients with SLE could be re-classified as high risk using a formula that incorporates SLE disease-related parameters. These patients have different profiles to those identified using a conventional risk model. Optimal CVD risk assessment and management warrants further attention in SLE.",
keywords = "cardiovascular risk, risk assessment, Systemic lupus erythematosus",
author = "Daniel Boulos and Koelmeyer, {Rachel L.} and Morand, {Eric F.} and Hoi, {Alberta Y.}",
year = "2017",
month = "7",
day = "1",
doi = "10.1136/lupus-2017-000212",
language = "English",
volume = "4",
journal = "Lupus Science and Medicine",
issn = "2053-8790",
publisher = "BMJ Publishing Group",
number = "1",

}

Cardiovascular risk profiles in a lupus cohort : What do different calculators tell us? / Boulos, Daniel; Koelmeyer, Rachel L.; Morand, Eric F.; Hoi, Alberta Y.

In: Lupus Science and Medicine, Vol. 4, No. 1, 000212, 01.07.2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Cardiovascular risk profiles in a lupus cohort

T2 - What do different calculators tell us?

AU - Boulos, Daniel

AU - Koelmeyer, Rachel L.

AU - Morand, Eric F.

AU - Hoi, Alberta Y.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background Cardiovascular disease (CVD) is the leading cause of death worldwide and this risk is increased in patients with SLE who may not conform to traditional cardiovascular risk profiles. Aims To determine the prevalence of high CVD risk among patients with SLE calculated using different risk calculators, and to characterise those identified as high risk. Methods A cross-sectional analysis to estimate CVD risk using the Framingham Risk Equation (Framingham score) and an SLE-specific CVD risk equation (SLE score) was undertaken using data from a single centre cohort. The characteristics of patients identified as â high risk' by the SLE score only (the â missed group') were compared with those identified by the Framingham score (the â conventional group'). Results 146 patients were included; 22 (15%) and 44 (30%) were determined to be at â high risk' based on the Framingham and SLE scores, respectively. Patients in the â missed group' were less likely to have traditional risk factors and were more likely to be female (81% vs 50%; p=0.03), younger (mean age 54 vs 69 years p<0.01) and have lower systolic blood pressure (132 vs 143 mm Hg; p=0.05). Of those deemed high risk, only a minority were treated to target blood pressure and lipid levels. Conclusions A large proportion of patients with SLE could be re-classified as high risk using a formula that incorporates SLE disease-related parameters. These patients have different profiles to those identified using a conventional risk model. Optimal CVD risk assessment and management warrants further attention in SLE.

AB - Background Cardiovascular disease (CVD) is the leading cause of death worldwide and this risk is increased in patients with SLE who may not conform to traditional cardiovascular risk profiles. Aims To determine the prevalence of high CVD risk among patients with SLE calculated using different risk calculators, and to characterise those identified as high risk. Methods A cross-sectional analysis to estimate CVD risk using the Framingham Risk Equation (Framingham score) and an SLE-specific CVD risk equation (SLE score) was undertaken using data from a single centre cohort. The characteristics of patients identified as â high risk' by the SLE score only (the â missed group') were compared with those identified by the Framingham score (the â conventional group'). Results 146 patients were included; 22 (15%) and 44 (30%) were determined to be at â high risk' based on the Framingham and SLE scores, respectively. Patients in the â missed group' were less likely to have traditional risk factors and were more likely to be female (81% vs 50%; p=0.03), younger (mean age 54 vs 69 years p<0.01) and have lower systolic blood pressure (132 vs 143 mm Hg; p=0.05). Of those deemed high risk, only a minority were treated to target blood pressure and lipid levels. Conclusions A large proportion of patients with SLE could be re-classified as high risk using a formula that incorporates SLE disease-related parameters. These patients have different profiles to those identified using a conventional risk model. Optimal CVD risk assessment and management warrants further attention in SLE.

KW - cardiovascular risk

KW - risk assessment

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85026436220&partnerID=8YFLogxK

U2 - 10.1136/lupus-2017-000212

DO - 10.1136/lupus-2017-000212

M3 - Article

VL - 4

JO - Lupus Science and Medicine

JF - Lupus Science and Medicine

SN - 2053-8790

IS - 1

M1 - 000212

ER -